Filing Details

Accession Number:
0001140361-14-043317
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-24 19:32:21
Reporting Period:
2014-11-21
Filing Date:
2014-11-24
Accepted Time:
2014-11-24 19:32:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594337 Corium International Inc. CORI Pharmaceutical Preparations (2834) 383230774
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241009 S Robert Breuil C/O Corium International, Inc.
235 Constitution Drive
Menlo Park CA 94025
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-21 3,000 $5.37 4,000 No 4 P Direct
Common Stock Acquisiton 2014-11-24 1,600 $5.40 5,600 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the aggregate of purchases effected on the same day at different prices.
  2. Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $5.345 to $5.39. Full information regarding the number of shares purchased at each price shall be provided, upon written request, to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. Includes 1,000 shares acquired under the Issuer's employee stock purchase plan on November 19, 2014.
  4. Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $5.33 to $5.55. Full information regarding the number of shares purchased at each price shall be provided, upon written request, to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.